- Dr Clement Goehrs, MD & PhD, Stanford graduate
- Dr Louis Letinier, MD, pharmacologist
- Bruno Thiao-Layel, research engineer.
Our founders identified a major issue in the healthcare system linked to drug information & misuse: In France, 10,000 to 30,000 deaths and 130,000 hospitalisations per year are related to this issue.
Synapse Medicine is a spinoff from leading Research Partner INSERM and Bordeaux University Hospital.
The company was formed after two years of intensive R&D. It has developed an AI platform enabling real-time access to official medication information.
Deployed as a SaaS application, the medication assistant helps physicians to prescribe more accurately. It also assists pharmacists to better deliver medication and advice, and enables patients to safely use and follow their treatments.
Synapse is a West Coast company (both in France and the US: Bordeaux & San Francisco). Our teams are made up of medication and artificial intelligence experts, physicians and pharmacists, data scientists and engineers. As well as seasoned business professionals who work in close partnership with key partners.
Creation of Synapse Medicine
Partnership with Stanford University, CA
Presentation at CES conference, Las Vegas, NV
Test phase in collaboration with prescribing healthcare professionals.
Award winner - Microsoft Experiences 18.
First start-up specialized in AI in collaboration with Bordeaux University Hospital
Large clinical trial - Bordeaux University Hospital ER department: evaluation of the Synapse drug interaction module.
Full-scale experimentation of Synapse algorithms with a group of healthcare insurance providers (sample: tens of thousands of patients).
Novel clinical study in conjunction with Bordeaux University Geriatrics Department.
Winner of a multimillion government funded 3-year research programme on iatrogenesis.
Launch of Synapse’s Patient Safety Application.
Synapse Medicine is a fast growing deep tech company.
We’re recruiting a wide range of roles to join our young and dynamic teams based either in the US or in Bordeaux, France.